MorphoSys AG Form SC TO-T/Amended Shows Novartis BidCo AG Bought 2,023,370 Shares Of Common Stock Or About A 5.36% Stake; Highest Price Paid Was €67.95 Per Share
MorphoSys AG Form SC TO-T/Amended Shows Novartis BidCo AG Bought 2,023,370 Shares Of Common Stock Or About A 5.36% Stake; Highest Price Paid Was €67.95 Per Share
On 11 April 2024, Novartis BidCo, Basel, Switzerland, ("Bidder") has published the offer document regarding its takeover offer (cash offer) to the shareholders of MorphoSys AG, Planegg, Germany ("MorphoSys") for the acquisition of all no-par value bearer shares (ISIN DE0006632003) ("MorphoSys Shares") including all no-par value bearer shares represented by American Depositary Shares (ISIN US6177602025) ("MorphoSys ADS") in MorphoSys against payment of a cash consideration in the amount of EUR 68.00 per MorphoSys Share. The acceptance period of the offer will expire on 13 May 2024, 24:00 hours (local time Frankfurt am Main, Germany) and 18:00 hours (local time New York, United States of America), unless it is extended pursuant to the applicable rules under the WpÜG.
2024年4月11日，位于瑞士巴塞尔的诺华BidCo（“投标人”）发布了关于其向德国普拉内格MorphoSys股份公司（“MorphoSys”）股东提出的收购要约（现金要约），以收购所有无面值不记名股票（ISIN DE0006632003）（“MorphoSys”）（“MorphoSys”）（“MorphoSys”）的收购要约（“MorphoSys”） 股票“）包括以MorphoSys的美国存托股票（ISIN US6177602025）（“MorphoSys ADS”）为代表的所有无面值不记名股票，以支付每股MorphoSys股票68.00欧元的现金对价。该优惠的接受期将于 2024 年 5 月 13 日 24:00（当地时间德国美因河畔法兰克福）和 18:00（当地时间美利坚合众国纽约）到期，除非根据WPUG的适用规则延长。
As of 12 April 2024 ("Reference Date"), i.e. after the publication of the offer document and prior to the publication pursuant to section 23 para. 1 sentence 1 no. 2 WpÜG, the Bidder acquired 2,023,370 MorphoSys Shares on the stock exchange. The highest price paid was EUR 67.95 per MorphoSys Share. The transfer of the 2,023,370 MorphoSys Shares to the Bidder is expected to take place within the next few days.
截至2024年4月12日（“参考日期”），即在要约文件发布之后，以及根据WPUg第23条第1款第1句发布之前，投标人在证券交易所收购了2,023,370股MorphoSys股票。支付的最高价格为每股MorphoSys股票67.95欧元。预计将在未来几天内向投标人转让2,023,370股MorphoSys股票。
The aggregate number of MorphoSys Shares for which purchase agreements were entered into on the Reference Date represents approx. 5.36 % of all MorphoSys Shares in existence on the Reference Date and approx. 5.37 % of all MorphoSys Shares in existence, other than treasury shares held by MorphoSys, on the Reference Date.
在基准日签订购买协议的MorphoSys股票总数约占基准日所有MorphoSys股票的5.36％，约占基准日除MorphoSys持有的库存股以外的所有MorphoSys现有股票的5.37％。